|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-1-21
|
|
pubmed:abstractText |
Differentiation between recurrent neoplasm and postradiation change in patients previously treated for primary brain tumors is often difficult based on imaging features alone. The purpose of this study was to develop a method using alterations in the ratios of standard brain metabolites-choline (Cho), creatine (Cr), and N-acetylaspartate (NAA)-to predict the probability of tumor recurrence in patients previously treated for brain tumors with new contrast-enhancing lesions.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1546-3141
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
192
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
W45-52
|
|
pubmed:dateRevised |
2009-11-25
|
|
pubmed:meshHeading |
pubmed-meshheading:19155380-Adolescent,
pubmed-meshheading:19155380-Adult,
pubmed-meshheading:19155380-Aged,
pubmed-meshheading:19155380-Aspartic Acid,
pubmed-meshheading:19155380-Brain Neoplasms,
pubmed-meshheading:19155380-Child,
pubmed-meshheading:19155380-Child, Preschool,
pubmed-meshheading:19155380-Choline,
pubmed-meshheading:19155380-Contrast Media,
pubmed-meshheading:19155380-Creatine,
pubmed-meshheading:19155380-Decision Support Systems, Clinical,
pubmed-meshheading:19155380-Female,
pubmed-meshheading:19155380-Gadolinium,
pubmed-meshheading:19155380-Humans,
pubmed-meshheading:19155380-Logistic Models,
pubmed-meshheading:19155380-Magnetic Resonance Spectroscopy,
pubmed-meshheading:19155380-Male,
pubmed-meshheading:19155380-Middle Aged,
pubmed-meshheading:19155380-Neoplasm Recurrence, Local,
pubmed-meshheading:19155380-ROC Curve,
pubmed-meshheading:19155380-Retrospective Studies,
pubmed-meshheading:19155380-Sensitivity and Specificity
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
|
|
pubmed:affiliation |
Department of Radiology, University of Michigan Health System, Ann Arbor, MI 48109-5030, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
